These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 6348409

  • 21. Anti-leprosy vaccines--field trials and future prospects.
    Deo MG.
    Indian J Lepr; 1984; 56(4):764-75. PubMed ID: 6442720
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Extended studies on subclinical infection in leprosy.
    Bharadwaj VP, Ramu G, Desikan KV, Katoch K.
    Indian J Lepr; 1984; 56(4):807-12. PubMed ID: 6398341
    [No Abstract] [Full Text] [Related]

  • 27. ELISA & lepromin skin tests in household contacts of leprosy patients.
    Dhandayuthapani S, Anandan D, Bhatia VN.
    Indian J Med Res; 1990 Nov; 91():431-6. PubMed ID: 2091988
    [Abstract] [Full Text] [Related]

  • 28. Antigeneic cross-reactivity between ICRC-bacilli and M. leprae--"in vitro" evaluation.
    Kale VP, Bapat CV.
    Indian J Lepr; 1984 Nov; 56(2):219-31. PubMed ID: 6387004
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Protective properties of M. lufu in experimental leprosy].
    Iushin MIu, Kalianina OV.
    Probl Tuberk; 1995 Nov; (2):47-8. PubMed ID: 7777465
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
    Majumder V, Mukerjee A, Hajra SK, Saha B, Saha K.
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
    [Abstract] [Full Text] [Related]

  • 33. Induction of lepromin positivity by a candidate anti-leprosy vaccine Mycobacterium w in lepromin negative healthy contacts of multibacillary leprosy patients.
    Kar HK, Sharma AK, Misra RS, Zaheer SA, Mukherjee A, Mukherjee R, Beena KR, Kaur H, Nair SK, Talwar GP.
    Indian J Lepr; 1992 Mar; 64(4):495-500. PubMed ID: 1308525
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The "Hansen-anergic fringe".
    Rotberg A.
    Acta Leprol; 1986 Mar; 4(3):347-54. PubMed ID: 3551473
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine.
    Sharma P, Kar HK, Misra RS, Mukherjee A, Kaur H, Mukherjee R, Rani R.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.